A Boston biotech sent its simulated organs to space on Artemis II. It could change space travel

Harvard's Wyss Institute and Emulate Bio say results from the AVATAR project could provide insights on how travel into deep ...
Business Wire

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
MarketWatch

Emulate Applauds FDA's Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies

Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
Technology Networks

Industrializing Organ-on-a-Chip Technology

Can organ-on-a-chip technology solve drug development’s biggest challenge—poor clinical success rates? Dr. Lorna Ewart ...
C&EN

FDA’s shift from animal testing opens doors for organoid makers

The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...
Reuters

Seres, Emulate collaborate to advance Emulate's intestine-chip platform

* Seres and Emulate will work to advance Emulate's intestine-chip platform, a living-tissue-based system that models human intestine ...